Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $88.17 Analyst target: $116.59 Upside: 32.23%
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
See the full interactive analysis & chart →Informational only — not investment advice.